BioCentury
ARTICLE | Clinical News

Oncolysin S: Began a Phase II trial

September 7, 1993 7:00 AM UTC

ImmunoGen Inc. (IMGN) Product: Oncolysin S, monoclonal antibody linked to blocked ricin Indication: Treat small-cell lung cancer Status: Began a Phase II trial ...